| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 07/22/2003 | US6596491 Tenascin-C nucleic acid ligands |
| 07/22/2003 | US6596481 Dual markers |
| 07/22/2003 | CA2241222C Linker arm for solid support oligonucleotide synthesis and process for production thereof |
| 07/22/2003 | CA2045891C Oligonucleotide analogs with terminal 3'-3' or 5'-5' internucleotide linkages |
| 07/17/2003 | WO2003045907A3 Sir2 products and activities |
| 07/17/2003 | US20030134807 Enzymatic nucleic acid synthesis: compositions and methods for altering monomer incorporation fidelity |
| 07/17/2003 | US20030134303 Adenine nucleotide-binding protein-directed probes, and methods of their synthesis and use |
| 07/17/2003 | US20030134290 Method for identifying polymorphisms |
| 07/16/2003 | EP1327637A1 Process for the preparation of L-Ribose |
| 07/16/2003 | EP1326876A2 Anhydro sugar derivatives of indolocarbazoles |
| 07/16/2003 | EP1326875A2 Tumor proliferation inhibitors |
| 07/16/2003 | EP1326874A2 Topoisomerase inhibitors |
| 07/16/2003 | EP1112066B1 Use of methoxymorpholino doxorubicin for the treatment of a liver tumor |
| 07/16/2003 | EP0828749B1 Methods for the synthesis of organophosphorus derivatives |
| 07/15/2003 | US6593467 Generating 5'-deoxy-5-fluorouridine; react 2',3'-O-isopropylidene-5- fluorouridine with a sulfonic derivative, hydrolyze, expose to iodine derivative, recover 5'-deoxy-5'-iodo-5-fluorouridine, |
| 07/15/2003 | US6593307 To antagonize cyclicADPRibose induced calcium release in a cell by contacting the cell with compound of invention |
| 07/15/2003 | US6593306 Methods for modulation and inhibition of telomerase |
| 07/15/2003 | US6593088 Reversible photocoupling nucleic acid and phosphoroamidite |
| 07/10/2003 | WO2003055898A1 Enzymatic redox labelling of nucleic acids |
| 07/10/2003 | WO2003055896A2 Anti-viral 7-deaza l-nucleosides |
| 07/10/2003 | WO2003010140A3 Hepatitis c virus polymerase inhibitors with heterobicyclic structure |
| 07/10/2003 | WO2003004511A3 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals |
| 07/10/2003 | WO2002100354A8 Pyrrolo[2,3-d]pyrimidine nucleoside analogs |
| 07/10/2003 | WO2002048331A3 Active-site engineering of nucleotidyltransferases and enzymatic methods for the synthesis of natural and 'unnatural' udp- and nucleotide sugars |
| 07/10/2003 | US20030130227 Uridine derivatives as antibiotics |
| 07/10/2003 | US20030130226 Prevent reproduction of viruses; genetic engineering |
| 07/10/2003 | US20030130213 Novel pyrazine derivatives or salts thereof, pharmaceutical composition containing the same, and production intermediates thereof |
| 07/10/2003 | US20030129615 Alpha modified nucleoside triphosphates |
| 07/10/2003 | CA2471109A1 Enzymatic redox labelling of nucleic acids |
| 07/10/2003 | CA2470521A1 Anti-viral 7-deaza l-nucleosides |
| 07/09/2003 | EP1325927A2 Synthesis of oligonucleotides |
| 07/09/2003 | EP1325017A2 Photocleavable protecting groups |
| 07/09/2003 | EP1325016A2 Nucleoside derivatives and a method for producing same |
| 07/09/2003 | EP1324761A2 Uridine therapy for patients with elevated purine levels |
| 07/09/2003 | EP0804446B1 Method and composition for stabilization of labelled nucleoside triphosphates |
| 07/09/2003 | EP0190315B2 Dehydrated liposomes |
| 07/09/2003 | CN1113894C Process for preparing intermediates of inhibitors of enkephalinase and angiotensin coverting enzyme and intermediates thereof |
| 07/09/2003 | CN1113892C Process for preparation of 2'fluoro-5-methyl-beta-L-arabino-furanosyluridine |
| 07/09/2003 | CN1113888C Tetraphosphonate bicyclic trisanhydrides |
| 07/08/2003 | US6590093 Orthoester protecting groups |
| 07/08/2003 | US6590085 Derivatives of monosaccharides as cell adhesion inhibitors |
| 07/08/2003 | US6589941 Preventing or reducing formation of resistance in cytostatic treatment comprising combining BVDU, a salt thereof or BVDU in protected form or in prodrug form with at least one cytostatic agent in order to prevent or reduce the formation |
| 07/08/2003 | US6589736 Photocleavable agents and conjugates for the detection and isolation of biomolecules |
| 07/08/2003 | CA2140428C Novel 2'-o-alkyl nucleosides and phosphoramidites processes for the preparation and uses thereof |
| 07/03/2003 | WO2003053989A1 Masked phosphate containing nucleoside derivatives and their use as antivirals |
| 07/03/2003 | WO2003053988A2 Avermectin b1 derivatives having an aminosulfonyloxy substituent in the 4''-position |
| 07/03/2003 | WO2003053360A2 Treatment of ebv and khsv infection and associated abnormal cellular proliferation |
| 07/03/2003 | US20030125300 Method and composition for conjugating molecules to nucleic acids |
| 07/03/2003 | US20030125263 Nucleic acid ligand complexes |
| 07/03/2003 | US20030124576 Such as (3-cyanocoumarinyl)dideoxyadenosine-5'-triphosphate which reacts with phosophatase to create detectable species (chemiluminescence, fluorescence); substrates for nucleic acid polymerases |
| 07/03/2003 | US20030124512 Simultaneous quantification of nucleic acids in diseased cells |
| 07/03/2003 | US20030124054 Antitumor agents; anticancer agents; viricides |
| 07/03/2003 | CA2470938A1 Treatment of ebv and khsv infection and associated abnormal cellular proliferation |
| 07/03/2003 | CA2469905A1 Avermectin b1 derivatives having an aminosulfonyloxy substituent in the 4''-position |
| 07/02/2003 | EP1323727A2 Composition and methods for the synthesis of organophosphorus derivatives |
| 07/02/2003 | EP1322784A1 System, method and apparatus for transgenic and targeted mutagenesis screening |
| 07/02/2003 | EP0628051B1 Applications of fluorescent n-nucleosides and fluorescent structural analogs of n-nucleosides |
| 07/02/2003 | CN1427846A Uridine derivatives as antibiotics |
| 07/02/2003 | CN1427722A Method for treatment or prevention of flavivirus infections using nucleoside analogues |
| 07/02/2003 | CN1427006A Preparation method of 2,2'-anhydro uridine compound |
| 07/01/2003 | US6586586 Separating analogs that have abasic sites by treating with a amino reactive reagent on a polymeric support; formation of imine groups |
| 07/01/2003 | US6586238 Enzymatic nucleic acids containing 5′-and or 3′-cap structures |
| 07/01/2003 | US6586193 Preferential detection of particle in sample; obtain sample, expose to light source, detect scattered light with eye, visibily scattered light indicates preferential particles in sample |
| 06/26/2003 | WO2003052134A2 Oligonucleotides comprising intercalator pseudonucleotide(s) for detection of nucleic acids and mutants hereof |
| 06/26/2003 | WO2003052133A2 Oligonucleotide analogues comprising intercalator pseudonucleotides |
| 06/26/2003 | WO2003052132A2 Linear and hairpin oligonucleotide analogues comprising intercalator pseudonucleotides |
| 06/26/2003 | WO2003052053A2 Nucleoside libraries and compounds by mcc combinatorial strategies on solid support |
| 06/26/2003 | WO2003051901A2 Pseudonucleotide comprising an intercalator |
| 06/26/2003 | WO2003051900A1 Derivatives of isoindigo, indigo and indirubin and use in treating cancer |
| 06/26/2003 | WO2003051899A1 Deazapurine nucleoside libraries and compounds |
| 06/26/2003 | WO2003051898A1 Unusual nucleoside libraries, compounds, and preferred uses as antiviral and anticancer agents |
| 06/26/2003 | WO2003051897A1 Nucleoside analog libraries and compounds |
| 06/26/2003 | WO2003051896A1 Cytidine libraries and compounds synthesized by solid-phase combinatorial strategies |
| 06/26/2003 | WO2003051881A1 Substituted purine nucleoside libraries and compounds by solid-phase combinatorial strategies |
| 06/26/2003 | WO2003051306A2 N4-acylcytosine-1,3-dioxolane nucleosides for treatment of viral infections |
| 06/26/2003 | WO2003051298A2 Preparation of intermediates useful in the synthesis of antiviral nucleosides |
| 06/26/2003 | US20030120071 Chemical compounds |
| 06/26/2003 | US20030120065 Diagnosis using triplex binding |
| 06/26/2003 | US20030120064 Processes for preparing beta-D-ribofuranose derivatives |
| 06/26/2003 | US20030120050 Modified internucleoside linkages (ii) |
| 06/26/2003 | US20030120035 Coupling oligonucleotide to solid support |
| 06/26/2003 | US20030119762 5'-substituted-ribofuranosyl benzimidazoles as antiviral agents |
| 06/26/2003 | US20030119040 Universal nucleotides for nucleic acid analysis |
| 06/26/2003 | US20030119011 Arrays for detecting nucleic acids |
| 06/26/2003 | US20030119008 Nucleotides and analogs having photoremovable protecting groups |
| 06/26/2003 | CA2470202A1 Preparation of intermediates useful in the synthesis of antiviral nucleosides |
| 06/25/2003 | EP1021388B1 Phosphorylation process and catalyst |
| 06/25/2003 | EP0880539B1 Nucleoside analogues |
| 06/25/2003 | EP0806957B1 Combination therapy for hiv infection using the hiv protease inhibitor indinavir adn the reverse transcriptase inhibitor 3tc together with azt. |
| 06/24/2003 | US6583168 Sulfonated diarylrhodamine dyes |
| 06/24/2003 | US6583122 Use in boron neutron capture therapy (BNCT) and diagnostic purposes; treating cancer, viral infections such as HIV, hepatitis B virus |
| 06/24/2003 | US6582923 Method for analyzing polynucleotides |
| 06/24/2003 | US6582908 Oligonucleotides |
| 06/19/2003 | WO2003050248A2 Adenine nucleotide-binding protein-directed probes and methods of their synthesis and use |
| 06/19/2003 | WO2003050242A2 Dna amplification and sequencing using dna molecules generated by random fragmentation |
| 06/19/2003 | US20030114663 Process for preparing purine nucleosides |
| 06/19/2003 | US20030114660 Hybrid oligonucleotide |
| 06/19/2003 | US20030113778 Enhanced in vitro nucleic acid synthesis using nucleoside monophosphates |
| 06/19/2003 | US20030113769 Aminooxy functionalized oligomers, oligomer arrays and methods of using them |
| 06/19/2003 | US20030113755 Fluorescent nucleotides and labeling methods using the same |